By continuing to use Symptoma®, you confirm you accept the cookies. More on
538401 to 538500 most common queries
List represents a sample of symptoms, diseases, and other queries. Updated weekly.
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma.
Response criteria for phase II studies of supratentorial malignant glioma.
A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes.
Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial.
Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings.
Home monitoring of foot skin temperatures to prevent ulceration.
A cohort study of people with diabetes and their first foot ulcer: the role of depression on mortality.
The diabetic foot: from art to science. The 18th Camillo Golgi lecture.
Glucose Decreased, Syncope
Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial.
Charcot-Marie-Tooth disease due to a de novo mutation of the RAB7 gene.
The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study.
Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes.
Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial.
Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies.
Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers.
Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists.
A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study.
The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study.
Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.
The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort.
Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population.
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology...
We should desist using RECIST, at least in GIST.
Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.
Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO.
PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib.
Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.
Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up.
Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.
KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours.
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib.
Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation.
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.
Gastrointestinal stromal tumors: pathology and prognosis at different sites.
Sunitinib: from rational design to clinical efficacy.
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033.
Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden.
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial.
Recent human-to-poultry host jump, adaptation, and pandemic spread of Staphylococcus aureus.
Surveillance of influenza A virus in migratory waterfowl in northern Europe.
Identification of pathogen-specific and conserved genes expressed in vivo by an avian pathogenic Escherichia coli strain.
Campylobacters as zoonotic pathogens: a food production perspective.
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia.
The biology and pathogenesis of coronaviruses.
Multilocus sequence typing for comparison of veterinary and human isolates of Campylobacter jejuni.
Sequence typing and comparison of population biology of Campylobacter coli and Campylobacter jejuni.
Observations by the ligated intestinal segment and oral inoculation methods on Escherichia coli infections in pigs, calves, lambs and rabbits.
Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses.
The genome sequence of avian pathogenic Escherichia coli strain O1:K1:H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes.
An update on the potential of north American mosquitoes (Diptera: Culicidae) to transmit West Nile Virus.
Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions.
Activation of the cellular oncogene c-erbB by LTR insertion: molecular basis for induction of erythroblastosis by avian leukosis virus.
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004.
Evolution of H5N1 avian influenza viruses in Asia.
Characterization of avian H5N1 influenza viruses from poultry in Hong Kong.
Anna Birna Jensdóttir
Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?
Re-emergence of fatal human influenza A subtype H5N1 disease.
Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes.
The mouse ocular albinism 1 gene product is an endolysosomal protein.
Motor and sensory characteristics of infantile nystagmus.
Oa1 knock-out: new insights on the pathogenesis of ocular albinism type 1.
Electroretinographic evidence for altered phototransduction gain and slowed recovery from photobleaches in albino mice with a MET450 variant in RPE65.
Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA).
Clinical features of affected males with X linked ocular albinism.
Behavioral visual responses of wild-type and hypopigmented zebrafish.
Abnormal foveal morphology in ocular albinism imaged with spectral-domain optical coherence tomography.
A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1.
Sex-linked ocular albinism displaying typical fundus changes in the female heterozygote.
Analysis of the OA1 gene reveals mutations in only one-third of patients with X-linked ocular albinism.
Amenorrhea, jaundice, glossitis
The ocular albinism type 1 gene product is a membrane glycoprotein localized to melanosomes.
Albinism and Hermansky-Pudlak syndrome in Puerto Rico.
Arrested development: high-resolution imaging of foveal morphology in albinism.
Ocular albinism: evidence for a defect in an intracellular signal transduction system.
Cloning of the gene for ocular albinism type 1 from the distal short arm of the X chromosome.
Modification of ocular defects in mouse developmental glaucoma models by tyrosinase.
From candelas to photoisomerizations in the mouse eye by rhodopsin bleaching in situ and the light-rearing dependence of the major components of the mouse ERG.
Purification of human erythropoietin.
Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.
Cancer in dyskeratosis congenita.
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
Bone-marrow transplantation (first of two parts).
Amenorrhea jaundice glossitis
Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.
Bone-marrow transplantation (second of two parts).
Dyskeratosis congenita in all its forms.
Aspergillosis. The spectrum of the disease in 98 patients.
Current concepts in the pathophysiology and treatment of aplastic anemia.